270 related articles for article (PubMed ID: 25764225)
1. Phosphoproteome characterization reveals that Sendai virus infection activates mTOR signaling in human epithelial cells.
Öhman T; Söderholm S; Paidikondala M; Lietzén N; Matikainen S; Nyman TA
Proteomics; 2015 Jun; 15(12):2087-97. PubMed ID: 25764225
[TBL] [Abstract][Full Text] [Related]
2. Global quantitative proteomic analysis profiles host protein expression in response to Sendai virus infection.
Zhu SL; Chen X; Wang LJ; Wan WW; Xin QL; Wang W; Xiao G; Zhang LK
Proteomics; 2017 Mar; 17(5):. PubMed ID: 28067018
[TBL] [Abstract][Full Text] [Related]
3. Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.
Kato A; Kiyotani K; Kubota T; Yoshida T; Tashiro M; Nagai Y
J Virol; 2007 Apr; 81(7):3264-71. PubMed ID: 17215288
[TBL] [Abstract][Full Text] [Related]
4. Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon.
Wetzel JL; Fensterl V; Sen GC
J Virol; 2014 Dec; 88(23):13593-601. PubMed ID: 25231314
[TBL] [Abstract][Full Text] [Related]
5. Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment.
Bousse T; Chambers RL; Scroggs RA; Portner A; Takimoto T
Virus Res; 2006 Oct; 121(1):23-32. PubMed ID: 16677733
[TBL] [Abstract][Full Text] [Related]
6. Identification of key genes and signaling pathways during Sendai virus infection in vitro.
Wei W; Kong W
Braz J Microbiol; 2019 Jan; 50(1):13-22. PubMed ID: 30637656
[TBL] [Abstract][Full Text] [Related]
7. Sendai virus C proteins must interact directly with cellular components to interfere with interferon action.
Garcin D; Curran J; Kolakofsky D
J Virol; 2000 Oct; 74(19):8823-30. PubMed ID: 10982324
[TBL] [Abstract][Full Text] [Related]
8. Sendai virus C protein inhibits lipopolysaccharide-induced nitric oxide production through impairing interferon-β signaling.
Odkhuu E; Komatsu T; Naiki Y; Koide N; Yokochi T
Int Immunopharmacol; 2014 Nov; 23(1):267-72. PubMed ID: 25242386
[TBL] [Abstract][Full Text] [Related]
9. Role of primary constitutive phosphorylation of Sendai virus P and V proteins in viral replication and pathogenesis.
Hu CJ; Kato A; Bowman MC; Kiyotani K; Yoshida T; Moyer SA; Nagai Y; Gupta KC
Virology; 1999 Oct; 263(1):195-208. PubMed ID: 10544094
[TBL] [Abstract][Full Text] [Related]
10. Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages.
Söderholm S; Kainov DE; Öhman T; Denisova OV; Schepens B; Kulesskiy E; Imanishi SY; Corthals G; Hintsanen P; Aittokallio T; Saelens X; Matikainen S; Nyman TA
Mol Cell Proteomics; 2016 Oct; 15(10):3203-3219. PubMed ID: 27486199
[TBL] [Abstract][Full Text] [Related]
11. Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice.
Kiyotani K; Sakaguchi T; Kato A; Nagai Y; Yoshida T
Virology; 2007 Mar; 359(1):82-91. PubMed ID: 17027894
[TBL] [Abstract][Full Text] [Related]
12. Inactivated Sendai virus induces apoptosis and autophagy via the PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer cells.
Zhang Q; Zhu H; Xu X; Li L; Tan H; Cai X
Biochem Biophys Res Commun; 2015 Sep; 465(1):64-70. PubMed ID: 26235873
[TBL] [Abstract][Full Text] [Related]
13. Verification of genetic loci responsible for the resistance/susceptibility to the Sendai virus infection using congenic mice.
Abbas RMF; Torigoe D; Kameda Y; Tag-El-Din-Hassan HT; Sasaki N; Morimatsu M; Agui T
Infect Genet Evol; 2018 Jan; 57():75-81. PubMed ID: 29128518
[TBL] [Abstract][Full Text] [Related]
14. Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection.
Bedsaul JR; Zaritsky LA; Zoon KC
J Interferon Cytokine Res; 2016 Nov; 36(11):652-665. PubMed ID: 27508859
[TBL] [Abstract][Full Text] [Related]
15. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A
Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Proteomics Identified TTC4 as a TBK1 Interactor and a Positive Regulator of SeV-Induced Innate Immunity.
Shang J; Xia T; Han QQ; Zhao X; Hu MM; Shu HB; Guo L
Proteomics; 2018 Jan; 18(2):. PubMed ID: 29251827
[TBL] [Abstract][Full Text] [Related]
17. DUSP1 regulates apoptosis and cell migration, but not the JIP1-protected cytokine response, during Respiratory Syncytial Virus and Sendai Virus infection.
Robitaille AC; Caron E; Zucchini N; Mukawera E; Adam D; Mariani MK; Gélinas A; Fortin A; Brochiero E; Grandvaux N
Sci Rep; 2017 Dec; 7(1):17388. PubMed ID: 29234123
[TBL] [Abstract][Full Text] [Related]
18. Mice deficient in NKLAM have attenuated inflammatory cytokine production in a Sendai virus pneumonia model.
Lawrence DW; Shornick LP; Kornbluth J
PLoS One; 2019; 14(9):e0222802. PubMed ID: 31539400
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
20. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
